Sameridine
Sameridine (NIH-10908) is a weak partial agonist of the μ-opioid (μ-opioid) receptor. Sameridine shows local anesthetic and analgesic properties when injected intrathecally. Sameridine has minimal respiratory depression at low doses, but can suppress ventilatory response at high doses. Sameridine can be used for the study of analgesic effect[1][2].
Product Specifications
CAS Number
[143257-97-0]
Product Name Alternative
NIH 10908 (free base)
UNSPSC
12352005
Hazard Statement
H312-H319
Target
Opioid Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
O=C(C1(CCN(CC1)CCCCCC)C2=CC=CC=C2)N(CC)C
Molecular Formula
C21H34N2O
Molecular Weight
330.51
Precautions
P264-P280-P302+P352-P305+P351+P338-P363-P501
References & Citations
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-105525/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
μ Opioid Receptor/MOR
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items